PALMIERI, Marta
 Distribuzione geografica
Continente #
NA - Nord America 3.580
EU - Europa 3.423
AS - Asia 1.376
OC - Oceania 9
SA - Sud America 9
AF - Africa 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 8.401
Nazione #
US - Stati Uniti d'America 3.550
GB - Regno Unito 1.660
CN - Cina 899
SG - Singapore 335
IT - Italia 330
SE - Svezia 245
FR - Francia 233
FI - Finlandia 210
DE - Germania 199
RU - Federazione Russa 199
IE - Irlanda 196
UA - Ucraina 67
TR - Turchia 43
BE - Belgio 34
CA - Canada 25
VN - Vietnam 16
KR - Corea 15
IR - Iran 14
JP - Giappone 14
NL - Olanda 13
IN - India 10
AU - Australia 8
ID - Indonesia 8
BR - Brasile 7
PL - Polonia 7
ES - Italia 5
MX - Messico 5
SA - Arabia Saudita 5
AT - Austria 4
CZ - Repubblica Ceca 4
TH - Thailandia 4
CH - Svizzera 3
HK - Hong Kong 3
MM - Myanmar 3
AL - Albania 2
BO - Bolivia 2
KG - Kirghizistan 2
MD - Moldavia 2
RO - Romania 2
TG - Togo 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BG - Bulgaria 1
BY - Bielorussia 1
EE - Estonia 1
EU - Europa 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
LU - Lussemburgo 1
MA - Marocco 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 8.401
Città #
Southend 1.547
Chandler 604
Jacksonville 561
Woodbridge 369
Ann Arbor 343
Singapore 293
Houston 210
Dublin 195
Ashburn 147
Verona 147
Beijing 143
Wilmington 120
Nanjing 111
New York 98
Lawrence 86
Princeton 86
Jinan 75
Helsinki 60
Shenyang 59
Changsha 45
Phoenix 45
Hebei 43
Venice 41
Tianjin 39
Zhengzhou 39
Falls Church 32
Brussels 30
Düsseldorf 30
Haikou 30
Boardman 29
Sindelfingen 27
Jiaxing 25
Ningbo 25
Redmond 24
Hangzhou 23
Nanchang 23
Redwood City 21
Norwalk 20
Milan 19
Taizhou 19
Guangzhou 18
Munich 18
Auburn Hills 15
Augusta 15
Seoul 14
Dallas 13
Los Angeles 13
Seattle 13
Tokyo 13
Fuzhou 11
San Mateo 11
Santa Clara 11
Taiyuan 11
Fairfield 10
Kent 10
Lanzhou 10
San Francisco 10
Dong Ket 9
Philadelphia 9
Toronto 9
Dearborn 8
London 8
Mestre 8
Jakarta 7
Leawood 7
Montréal 7
Ardabil 6
Detroit 6
Elora 6
Moscow 6
San Diego 6
Monmouth Junction 5
Mumbai 5
San Giovanni Ilarione 5
Warsaw 5
Washington 5
Andover 4
Bologna 4
Cleveland 4
Cuauhtémoc 4
Riyadh 4
Vienna 4
Amsterdam 3
Cambridge 3
Chions 3
Clearwater 3
Edinburgh 3
Ghent 3
Hong Kong 3
Newark 3
Shanghai 3
Tappahannock 3
Yangon 3
Bishkek 2
Caerano di San Marco 2
Carate Brianza 2
Caserta 2
Chisinau 2
Cooperstown 2
Falkenstein 2
Totale 6.297
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 224
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 165
Secretome protein signature of human pancreatic cancer stem-like cells 164
Pancreatic cancer stem cells characterization and secretome analysis 143
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 140
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 140
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 140
SHOTGUN PROTEOMIC ANALYSIS OF PANCREATIC CANCER STEM CELLS 139
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 132
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 128
Protein synthesis inhibitors cycloheximide and anisomycin induce interleukin-6 gene expression and activate transcription factor NF-kappa-B 127
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 126
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 124
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 123
Nuclear factor kappa-B (NF-kappa-B), nuclear factor interleukin-6 (NFIL-6 or C/EBP-beta) and nuclear factor interleukin-6-beta (NFIL6-beta or C/EBP-delta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell 122
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 121
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 119
Bovine seminal ribonuclease precursor synthesized in vitro 116
Cell-specific differences in the regulation of IL-6 expression by PMA 114
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 114
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 112
Regulation of miR-23b expression and its dual role on ROS production and tumour development 111
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 111
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 110
Protein-DNA interactions in the 5'-flanking region of the bovine pancreatic ribonuclease gene 109
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 108
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 108
Qβ DNA-containing hybrid plasmids giving rise to Qβ phage formation in the bacterial host 107
Nuclear factor kB, nuclear factor interleukin-6 (NFIL6 or C/EBPbeta) and nuclear factor interleukin-6beta (NFIL6beta or C/EBPdelta) are not sufficient to activate the endogenous interleukin-6 gene in the human breast carcinoma cell line MCF-7. Comparative analysis with MDA-MB-231 cells, an interleukin-6 expressing human breast carcinoma cell line. 106
Proteomic analysis of pancreatic cancer stem cells: Functional role of fatty acid synthesis and mevalonate pathways 106
A Qbeta DNA-containing hybrid plasmid giving rise to Qbeta phage formation in the bacterial host [proceedings] 105
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 105
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 105
Lithostathine messenger RNA expression in different types of chronic pancreatitis. 105
How much is secondary structure responsible for resistance of double-stranded RNA to pancreatic ribonuclease A? 102
[Endonucleolytic mechanism of degradation of double-helix RNA by ribonuclease BS-1 and by ribonuclease A aggregates] 102
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 102
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 102
Pancreatic ductal adenocarcinoma cell lines display a plastic ability to bi‑directionally convert into cancer stem cells 102
Expression of opioid genes in bovine seminal vesicles. 101
Proteomics in pancreatic cancer research. 101
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 99
Repression of the IL-6 gene is associated with hypermethylation. 98
A pancreatic-like ribonuclease is synthesized in rat brain 97
Differential, structure-dependent susceptibily of poli(A) and RNA to monomeric and dimeric pancreatic ribonuclease A. 94
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 93
The differential pattern of tissue specific expression of ruminant pancreatic type ribonucleases may help to understand the evolutionary history of their genes. 91
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 91
Molecular mechanisms regulating induction of interleukin-6 gene transcription by interferon-gamma. 90
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 89
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 88
Sequence analysis of a cloned cDNA coding for bovine seminal ribonuclease 87
The metabolic landscape of cancer stem cells 87
UCP2, a mitochondrial protein regulated at multiple levels 84
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 82
[Influence of the ionic strength on the effect of monomeric and dimeric RNAse on poly(A)] 81
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 81
In vitro synthesis of pig pancreas ribonuclease. 80
GAAP-1: A transcriptional activator of p53 and IRF-1 possesses pro-apoptotic activity 79
Interleukin-6 repression is associated with a distinctive chromatin structure of the gene. 77
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 77
[Structure-dependent differential susceptibility of poly(A) to pancreatic ribonuclease and to ribonuclease BS-1] 76
Genomic footprinting: detection of putative regulatory proteins in the promoter region of the interferon-alpha-1 gene in normal human tissues. 76
Sequences related to the ox pancreatic ribonuclease coding region in the genomic DNA of mammalian species 76
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 76
Extracellular Matrix composition modulates PDAC parenchymal and stem cell plasticity and behavior through the secretome 76
[Relationship between the basicity of the ribonuclease molecule and the degradation of double spiral RNA: recent contribution] 75
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 74
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 73
Molecular cloning of the gene encoding the bovine brain ribonuclease and its expression in different regions of the brain. 72
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 72
Oncometabolites in cancer aggressiveness and tumour repopulation 72
Progressively de-differentiated pancreatic cancer cells shift from glycolysis to oxidative metabolism and gain a quiescent stem state 69
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 69
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 68
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 68
Single-stranded RNA viruses inactivate the transcriptional activity of p53 but induce NOXA-dependent apoptosis via post-translational modifications of IRF-1, IRF-3 and CREB 65
Structure of the bovine pancreatic ribonuclease gene: the unique intervening sequence in the 5' untraslated region contains a promoter-like element. 64
Molecular evolution of genes encoding ribonucleases in ruminant species. 61
Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate‑copper complex loaded into hyaluronic acid decorated liposomes 59
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 59
Integrated lipidomics and proteomics reveal cardiolipin alterations, upregulation of HADHA and long chain fatty acids in pancreatic cancer stem cells 59
Interaction of the nuclear protein CBF1 with the kB site of the IL-6 gene promoter. 58
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 58
Mitochondrial Elongation and OPA1 Play Crucial Roles during the Stemness Acquisition Process in Pancreatic Ductal Adenocarcinoma 55
Secreted molecules inducing epithelial-to-mesenchymal transition in cancer development 55
Regulation of succinate dehydrogenase and role of succinate in cancer 45
Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells 24
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 21
Increased stability of P21(WAF1/CIP1) mRNA is required for ROS/ERK-dependent pancreatic adenocarcinoma cell growth inhibition by pyrrolidine dithiocarbamate 21
Totale 8.482
Categoria #
all - tutte 26.813
article - articoli 24.721
book - libri 0
conference - conferenze 2.092
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.626


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020681 0 0 0 0 147 112 59 74 48 97 52 92
2020/2021895 165 121 30 83 87 93 16 62 64 8 132 34
2021/2022810 109 173 18 59 36 26 31 42 33 20 79 184
2022/20231.685 122 182 143 315 152 341 25 111 190 54 34 16
2023/2024723 31 77 46 98 90 150 18 47 9 34 98 25
2024/2025661 85 139 64 306 67 0 0 0 0 0 0 0
Totale 8.482